StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.01+0.03 (+3.30%)

Close on Nov 17, 2026Market cap $19.46MP/E –Yield –

Cocrystal Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cocrystal Pharma's market cap was $14.06M on Nov 11, 2026, against $13.82M a year earlier. Over the last 5 years it ranged from $1.32M to $63.36M, with a median of $16.00M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$14.06M+10.2%
2025Dec 31, 2025$12.77M-37.9%
2024Dec 31, 2024$20.55M+17.3%
2023Dec 29, 2023$17.52M+1224.2%
2022Dec 30, 2022$1.32M-97.9%
2021Dec 31, 2021$63.36M-32.1%
2020Dec 31, 2020$93.25M+495.1%
2019Dec 31, 2019$15.67M-85.5%
2018Dec 31, 2018$107.73M-26.0%
2017Dec 29, 2017$145.67M-47.7%
2016Dec 30, 2016$278.47M-54.9%
2015Dec 31, 2015$617.99M+1202035.1%
2014Dec 31, 2014$51.41K-100.0%
2013Dec 31, 2013$4.45B-78.3%
2012Dec 31, 2012$20.52B–

More Cocrystal Pharma figures

See a number that looks wrong?